Form 4: Pfizer Executive Vice President Acquires Phantom Stock Units

Pfizer's Executive Vice President, Rady A. Johnson, acquired 7 phantom stock units through the company's Supplemental Savings Plan.

Summary

• Rady A. Johnson, an Executive Vice President at Pfizer, acquired 7 phantom stock units on December 13, 2024.
• These units were acquired through the Pfizer Supplemental Savings Plan.
• Each unit represents one phantom share of Pfizer common stock.
• The units are settled in cash after the reporting person's separation from service.
• The reporting person can transfer the units into an alternative investment account at any time.
• Following the transaction, Mr. Johnson directly owns 9,373 shares of Pfizer common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally viewed neutrally to positively by investors. The acquisition of phantom stock units can be seen as a positive sign of executive confidence in the company.

Positives

• The acquisition of phantom stock units by an executive may indicate confidence in the company's future performance.

Industry Context

This is a routine filing related to executive compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Many large pharmaceutical companies use phantom stock units as part of their executive compensation packages.
• These plans are designed to align executive interests with shareholder value.
• The use of a Supplemental Savings Plan is a common method for providing deferred compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.

Key Dates

Keywords

Pfizer, phantom stock units, executive compensation, insider trading, Form 4, Supplemental Savings Plan, Rady A. Johnson